unknown
Stage
4
Investors
About
Concert Bio is a biotechnology company developing novel therapeutics for autoimmune diseases and cancer. They leverage advanced computational biology and immunology to identify drug targets and develop precision medicines.
Explore Concert Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.